Sebastian Heidenreich
Thermo Fisher Scientific, 201 Talgarth Road, Hammersmith
London, ENG W68BJ, United Kingdom
London, ENG W68BJ, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Women's Treatment Preferences for Moderate to Severe Vasomotor Symptoms Associated with Menopause: Insights from the WARMER Study.
Journal: The patient
Published: November 03, 2025
Patient preferences for EGFR mutation-targeted therapies in non-small cell lung cancer, with a focus on Exon 20 insertions.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 26, 2025
Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation.
Journal: Applied health economics and health policy
Published: January 19, 2025
Extending Multidimensional Thresholding to Include Categorical Attributes.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 12, 2024
Patient Preferences for HR+/HER2- Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment.
Journal: Breast care (Basel, Switzerland)
Published: September 30, 2024
Is next generation sequencing for the diagnosis of rare diseases worth its cost? A user-based approach to valuation.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: September 04, 2024
Patient Preferences for First-Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: An Application of Multidimensional Thresholding.
Journal: The patient
Published: July 25, 2024
Preferences of US adolescents and parents for vaccination against invasive meningococcal disease.
Journal: Vaccine
Published: March 13, 2024
Benefit-Risk Trade-offs and Patient Preferences for Therapy Selection in Ulcerative Colitis: a Multicountry Preference Study.
Journal: Inflammatory bowel diseases
Published: March 05, 2024
Preferences of Patients with Amyotrophic Lateral Sclerosis for Intrathecal Drug Delivery: Choosing between an Implanted Drug-Delivery Device and Therapeutic Lumbar Puncture.
Journal: The patient
Published: November 29, 2023
Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis.
Journal: The European journal of health economics : HEPAC : health economics in prevention and care
Published: November 15, 2023
Last Updated: 09/26/2026